Nonoperating Income (Expense) in USD of ABVC BIOPHARMA, INC. from 2011 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Abvc Biopharma, Inc. quarterly/annual Nonoperating Income (Expense) history and change rate from 2011 to Q3 2025.
  • Abvc Biopharma, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2025 was -$119K, a 35.8% increase year-over-year.
  • Abvc Biopharma, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2025 was -$476K, a 18.7% increase year-over-year.
  • Abvc Biopharma, Inc. annual Nonoperating Income (Expense) for 2024 was -$664K, a 47.2% increase from 2023.
  • Abvc Biopharma, Inc. annual Nonoperating Income (Expense) for 2023 was -$1.26M, a 214% decline from 2022.
  • Abvc Biopharma, Inc. annual Nonoperating Income (Expense) for 2022 was -$400K, a 181% decline from 2021.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Change (%)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Change (%)

ABVC BIOPHARMA, INC. Quarterly Nonoperating Income (Expense) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$476K -$119K +$66.2K +35.8% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-03
Q2 2025 -$542K -$14.2K +$284K +95.2% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-13
Q1 2025 -$826K -$251K -$162K -181% Jan 1, 2025 Mar 31, 2025 10-Q 2025-04-30
Q4 2024 -$664K -$92K -$78.8K -599% Oct 1, 2024 Dec 31, 2024 10-K 2025-04-15
Q3 2024 -$586K -$185K +$1.03M +84.8% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-03
Q2 2024 -$1.61M -$298K -$259K -651% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-13
Q1 2024 -$1.36M -$89.4K -$98.4K -1099% Jan 1, 2024 Mar 31, 2024 10-Q 2025-04-30
Q4 2023 -$1.26M -$13.2K Oct 1, 2023 Dec 31, 2023 10-K 2025-04-15
Q3 2023 -$1.21M Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 -$39.7K Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 $8.95K +$18.4K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-17
Q1 2022 $415K -$9.41K -$80.4K -113% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $495K $493K +$697K Oct 1, 2021 Dec 31, 2021 10-K 2022-03-31
Q3 2021 -$202K $8.64K +$895K Jul 1, 2021 Sep 30, 2021 10-Q 2021-11-15
Q2 2021 -$1.1M -$77K +$962K +92.6% Apr 1, 2021 Jun 30, 2021 10-Q 2021-08-12
Q1 2021 -$2.06M $71K +$249K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 -$2.31M -$205K -$186K -964% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 -$2.12M -$886K -$721K -435% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$1.4M -$1.04M -$872K -524% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$530K -$178K +$21.8K +10.9% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 -$552K -$19.3K +$2.84M +99.3% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-16
Q3 2019 -$3.4M -$166K +$195K +54% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-17
Q2 2019 -$3.59M -$166K +$122K +42.3% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 -$3.71M -$200K -$66.6K -49.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-06-29
Q4 2018 -$3.65M -$2.86M -$2.83M -9973% Oct 1, 2018 Dec 31, 2018 10-K 2020-05-15
Q3 2018 -$811K -$360K -$333K -1211% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-18
Q2 2018 -$478K -$288K -$260K -916% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 -$218K -$134K -$115K -604% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-28
Q4 2017 -$103K -$28.4K -$28.5K Oct 1, 2017 Dec 31, 2017 10-KT 2018-04-13
Q3 2017 -$74.8K -$27.5K +$31.1K +53.1% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$106K -$28.4K -$25.1K -760% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-20
Q1 2017 -$80.8K -$19K -$71K -137% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 -$9.81K $49.00* -$143 Oct 1, 2016 Dec 31, 2016 10-KT 2018-04-13
Q3 2016 -$9.67K -$58.6K Jul 1, 2016 Sep 30, 2016 10-KT 2018-04-13
Q2 2016 -$3.3K -$3.3K Apr 1, 2016 Jun 30, 2016 10-Q 2018-03-19
Q1 2016 $52K +$52K Jan 1, 2016 Mar 31, 2016 10-Q/A 2018-03-19
Q4 2015 $192 +$192 Oct 1, 2015 Dec 31, 2015 10-Q/A 2018-03-19
Q2 2015 $0 $0 Apr 1, 2015 Jun 30, 2015 10-Q 2015-08-19
Q1 2015 $0 $0 Jan 1, 2015 Mar 31, 2015 10-Q 2015-06-05
Q4 2014 $0 $0 Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-23
Q2 2014 $0 $0 +$16.5K Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-19
Q1 2014 -$16.5K $0 +$16.2K Jan 1, 2014 Mar 31, 2014 10-Q 2015-06-05
Q4 2013 -$32.7K $0 +$16.4K Oct 1, 2013 Dec 31, 2013 10-Q 2015-04-17
Q3 2013 -$49.1K $0 +$14.9K Jul 1, 2013 Sep 30, 2013 10-K 2015-04-16
Q2 2013 -$64K -$16.5K -$3.04K -22.5% Apr 1, 2013 Jun 30, 2013 10-Q 2015-04-17
Q1 2013 -$61K -$16.2K -$3.9K -31.7% Jan 1, 2013 Mar 31, 2013 10-Q 2015-04-17
Q4 2012 -$57.1K -$16.4K -$198K -109% Oct 1, 2012 Dec 31, 2012 10-Q 2015-04-17
Q3 2012 $141K -$14.9K Jul 1, 2012 Sep 30, 2012 10-K 2015-04-16
Q2 2012 -$13.5K Apr 1, 2012 Jun 30, 2012 10-Q 2015-04-16
Q1 2012 -$12.3K Jan 1, 2012 Mar 31, 2012 10-Q 2015-04-16
Q4 2011 $182K Oct 1, 2011 Dec 31, 2011 10-Q 2015-04-16

ABVC BIOPHARMA, INC. Annual Nonoperating Income (Expense) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$664K +$594K +47.2% Jan 1, 2024 Dec 31, 2024 10-K 2025-04-15
2023 -$1.26M -$858K -214% Jan 1, 2023 Dec 31, 2023 10-K 2025-04-15
2022 -$400K -$895K -181% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-13
2021 $495K +$2.8M Jan 1, 2021 Dec 31, 2021 10-K 2022-03-31
2020 -$2.31M -$1.76M -319% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
2019 -$552K +$3.09M +84.9% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-16
2018 -$3.65M -$3.54M -3429% Jan 1, 2018 Dec 31, 2018 10-K 2020-05-15
2017 -$103K -$93.6K -968% Jan 1, 2017 Dec 31, 2017 10-K 2019-04-15
2016 -$9.67K Oct 1, 2015 Sep 30, 2016 10-KT 2018-04-13
2013 -$49.1K -$190K -135% Oct 1, 2012 Sep 30, 2013 10-K 2015-04-16
2012 $141K -$528K -78.9% Oct 1, 2011 Sep 30, 2012 10-K 2015-04-16
2011 $669K Oct 1, 2010 Sep 30, 2011 10-K 2015-04-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.